Eargo

Eargo, Inc. is engaged in the development of hearing aids and headsets solutions. Its products include Eargo Neo HiFi, Eargo Neo, Eargo Max, and Eargo Accessories. The company was founded by Florent Michel, Raphael Michel, and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q4 2021

Earnings data Q3 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Eargo reports robust Q1 revenue growth and positive customer feedback

Eargo's Q1 2023 earnings call showcased strong revenue growth, positive customer feedback for Eargo 7, and progress in evolving into an omnichannel business. While the company faces challenges in managing return rates and marketing expenses, it has opportunities to capitalize on its momentum and drive further growth through strategic partnerships and product innovation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SAN JOSE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will release financial results for the fourth quarter and full year 2020 after market close on February 25, 2021. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Eargo to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

SAN JOSE, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced its preliminary unaudited net revenue and preliminary gross systems shipped for the fourth quarter and year ended December 31, 2020. 1

Eargo Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Net Revenue and Preliminary Gross Systems Shipped

SAN JOSE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 39th Annual J.P. Morgan Healthcare Conference via web cast. Christian Gormsen, Eargo's President and Chief Executive Officer, is scheduled to present on Tuesday, January 12th at 2:00pm Eastern Time.

Eargo to Present at 39th Annual J.P. Morgan Healthcare Conference

Eargo is also named to “Best Company for Women” and “Best CEOs” list Eargo is also named to “Best Company for Women” and “Best CEOs” list

Eargo Ranks First for Best Company Culture in Comparably Awards

Nano-X Imaging

Outset Medical

Silk Road Medical Inc

Transmedics Group Inc

LONDON--(BUSINESS WIRE)--Deep Pharma Intelligence names Nanox Imaging (NASDAQ:NNOX), TransMedics, Inc. (NASDAQ: TMDX), Outset Medical, Inc. (NASDAQ:OM), Eargo, Inc. (NASDAQ:EAR), and Silk Road Medical, Inc. (NASDAQ:SILK) as best Health-Tech companies to watch in 2021-2022. The report provides an overview and brief assessment of 5 highly impactful and promising medical hardware technologies to be watched in 2021-2022, and the companies behind their development and commercialization. In the case

Deep Pharma Intelligence Names Nanox, TransMedics, Outset, Eargo, and Silkroad as Best Health-Tech Companies to Watch in 2021-2022

Net revenues of $18.2 million, up 135.3% year-over-year

Eargo Reports Third Quarter 2020 Financial Results

SAN JOSE, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Eargo Inc., (NASDAQ: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will release financial results for the third quarter of 2020 after market close on Thursday, November 19, 2020. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Eargo to Announce Third Quarter 2020 Financial Results

News for Eargo Stock (EAR)